Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current Medicinal Chemistry

• Publication date

  2002-02-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/0929867023370789PMID 11945128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group.

  1999cited by this paper
• Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.

  1999cited by this paper
• PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

  1999cited by this paper
• Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1*

  1999cited by this paper
• Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene

  1999cited by this paper
• Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.

  1999cited by this paper
• Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.

  1998cited by this paper
• Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators

  1998cited by this paper
• Molecular Determinants of AHPN (CD437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines

  1998cited by this paper
• Regulation of RARβ expression by RAR‐ and RXR‐selective retinoids in human lung cancer cell lines: Effect on growth inhibition and apoptosis induction

  1998cited by this paper
• Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators

  1998cited by this paper
• Evidence for the involvement of both retinoic acid receptor- and retinoic X receptor-dependent signaling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226.

  1998cited by this paper
• Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.

  1998cited by this paper
• Serine 232 and Methionine 272 Define the Ligand Binding Pocket in Retinoic Acid Receptor Subtypes*

  1998cited by this paper
• Effects of trans-retinoic acid, 9-cis-retinoic acid, 1alpha,25-(dihydroxy)vitamin D3 and a novel apoptosis-inducing retinoid on breast cancer and endothelial cell growth.

  1998cited by this paper
• Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements.

  1998cited by this paper
• Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia

  1998cited by this paper
• Nuclear receptor coactivators.

  1997cited by this paper
• Retinoic Acid Receptor/Retinoid X Receptor Heterodimers Can Be Activated through Both Subunits Providing a Basis for Synergistic Transactivation and Cellular Differentiation*

  1997cited by this paper
• Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP‐TF and their heterodimerization

  1997cited by this paper
• Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids

  1997cited by this paper
• High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells.

  1997cited by this paper
• Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.

  1997cited by this paper
• Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.

  1997cited by this paper
• Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture.

  1997cited by this paper
• Activation of Three Distinct RXR/RAR Heterodimers Induces Growth Arrest and Differentiation of Neuroblastoma Cells*

  1997cited by this paper
• Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells

  1996cited by this paper
• Role of CBP/P300 in nuclear receptor signalling

  1996cited by this paper
• Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.

  1996cited by this paper
• Ligand-induced Conformational Changes in the Human Retinoic Acid Receptor γ Detected Using Monoclonal Antibodies*

  1996cited by this paper
• Phase I trial of 9-cis retinoic acid in adults with solid tumors.

  1996cited by this paper
• Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.

  1996cited by this paper
• A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.

  1996cited by this paper
• Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

  1995cited by this paper
• Retinoic acid nuclear receptor β inhibits breast carcinoma anchorage independent growth

  1995cited by this paper
• Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.

  1995cited by this paper
• Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.

  1995cited by this paper
• A transcriptional co-repressor that interacts with nuclear hormone receptors

  1995cited by this paper
• Polarity-specific activities of retinoic acid receptors determined by a co-repressor

  1995cited by this paper
• A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors.

  1995cited by this paper
• Unique response pathways are established by allosteric interactions among nuclear hormone receptors.

  1995cited by this paper
• Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

  1995cited by this paper
• Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding

  1994cited by this paper
• Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.

  1994cited by this paper
• Acute promyelocytic leukemia.

  1993cited by this paper
• 9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro.

  1993cited by this paper
• RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo.

  1993cited by this paper
• Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.

  1993cited by this paper
• Retinoids selective for retinoid X receptor response pathways.

  1992cited by this paper
• Carotenoids and retinoids in human nutrition.

  1992cited by this paper
• Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid

  1992cited by this paper
• Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

  1992cited by this paper
• 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

  1992cited by this paper
• 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

  1992cited by this paper
• Identification of retinoids with nuclear receptor subtype-selective activities.

  1991cited by this paper
• 6'-substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands.

  1991cited by this paper
• Antagonism between retinoic acid receptors

  1991cited by this paper
• Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.

  1990cited by this paper
• Nuclear receptor that identifies a novel retinoic acid response pathway

  1990cited by this paper
• Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

  1990cited by this paper
• Binding affinities of retinoids to fetal cellular retinoic acid-binding protein (CRABP) in relation to their teratogenic potency in hamsters.

  1990cited by this paper
• Spatial and temporal expression of the retinoic acid receptor in the regenerating amphibian limb

  1989cited by this paper
• Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids.

  1989cited by this paper
• A third human retinoic acid receptor, hRAR-gamma.

  1989cited by this paper
• Identification of a new class of steroid hormone receptors

  1988cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Identification of a second human retinoic acid receptor

  1988cited by this paper
• A new retinoic acid receptor identified from a hepatocellular carcinoma

  1988cited by this paper
• Retinoic acid and thyroid hormone induce gene expression through a common responsive element

  1988cited by this paper
• Identification of a receptor for the morphogen retinoic acid

  1987cited by this paper
• A human retinoic acid receptor which belongs to the family of nuclear receptors

  1987cited by this paper
• Role of retinoids in differentiation and carcinogenesis.

  1983cited by this paper
• Aromatic retinoic acid analogues. 2. Synthesis and pharmacological activity.

  1983cited by this paper
• Synthesis and pharmacological activity of 6-[(E)-2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethen-1-yl]- and 6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acids.

  1983cited by this paper
• Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells.

  1983cited by this paper
• Aromatic retinoic acid analogues. Synthesis and pharmacological activity.

  1981cited by this paper
• Retinoic acid analogues. Synthesis and potential as cancer chemopreventive agents.

  1980cited by this paper
• Structure-activity relationships of retinoids in hamster tracheal organ culture.

  1980cited by this paper
• Chemoprevention of cancer with retinoids.

  1979cited by this paper
• In vitro metabolism and biological activity of all-trans-retinoic acid and its metabolites in hamster trachea.

  1978cited by this paper
• Synthesis of prostaglandin synthetase substrate analogues. 2. (8Z,11Z,14Z)-15-Methyl-8,11,14-eicosatrienoic acid.

  1977cited by this paper
• Letter: Allenic retinals and visual pigment analogues.

  1976cited by this paper
• Relationships between structure and activity of retinoids

  1976cited by this paper
• Activity of vitamin A analogues in cell cultures of mouse epidermis and organ cultures of hamster trachea

  1975cited by this paper
• Histogenesis of squamous metaplasia in the hamster tracheal epithelium caused by vitamin A deficiency or benzo[a]pyrene-Ferric oxide.

  1972cited by this paper
• Fatty acid synthetase activity in Mycobacterium phlei: regulation by polysaccharides.

  1971cited by this paper

• Structural insights into retinoic acid receptor activation and selective modulators

  2025cites this paper
• Nuclear receptor RXRα binds the precursor of miR-103 to inhibit its maturation

  2023cites this paper
• Design, synthesis and biological evaluation of acyl hydrazones-based derivatives as RXRα-targeted anti-mitotic agents.

  2022cites this paper
• Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies.

  2021cites this paper
• Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review

  2020cites this paper
• Structure-Activity Relationship Study Enables the Discovery of a Novel Berberine Analogue as RXRα Activator to Inhibit Colon Cancer.

  2020cites this paper
• Centrosomal Localization of RXRα Promotes PLK1 Activation and Mitotic Progression and Constitutes a Tumor Vulnerability.

  2020cites this paper
• Cytotoxic polyprenylated phloroglucinol derivatives from Hypericum elodeoides Choisy modulating the transactivation of RXRα.

  2020cites this paper
• Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer

  2020cites this paper
• Discovery of atorvastatin as a tetramer stabilizer of nuclear receptor RXRα through structure-based virtual screening.

  2019cites this paper
• Oncogenic potential of truncated RXRα during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling

  2019cites this paper
• Overview of the structure-based non-genomic effects of the nuclear receptor RXRα

  2018cites this paper
• Natural and Structure-based RXR Ligand Scaffolds and Their Functions.

  2017cites this paper
• Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells

  2017cites this paper
• Norsampsone E, an unprecedented decarbonyl polycyclic polyprenylated acylphloroglucinol with a homoadamantyl core from Hypericum sampsonii

  2017cites this paper
• Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.

  2017cites this paper
• Function of all-trans retinoic acid observation on similar myopia changes in cultivated rabbit retinal pigment epithelium and relation with myopia relevant factors.

  2016cites this paper
• The Function of Retinoid X Receptor α in Cancer Cells

  2016cites this paper
• Binding characterization, synthesis and biological evaluation of RXRα antagonists targeting the coactivator binding site.

  2016cites this paper
• All-trans retinoic acid up-regulates the human CD2AP gene expression through Sp1/Sp3 binding sites

  2015cites this paper
• Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β‐catenin and nuclear factor‐κB pathways

  2015cites this paper
• Targeting truncated RXRα for cancer therapy.

  2015cites this paper
• Bioactive prenylated xanthones from the stems of Cratoxylum cochinchinense

  2015cites this paper
• Retinoid Receptor‐Selective Modulators

  2015cites this paper
• Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites

  2014cites this paper
• Retinoic acid receptors: structural basis for coregulator interaction and exchange.

  2014cites this paper
• Effekt von Retinol auf postprandiale Parameter bei Männern mit verschiedenen FABP2 Promoter Haplotypen

  2014cites this paper
• Identification of a New RXRα Antagonist Targeting the Coregulator-Binding Site

  2014cites this paper
• Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site.

  2014cites this paper
• BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells.

  2014cites this paper
• Functions, therapeutic applications, and synthesis of retinoids and carotenoids.

  2014cites this paper
• Explant cultures of Rpe65−/− mouse retina: a model to investigate cone opsin trafficking

  2013cites this paper
• Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.

  2013cites this paper
• Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation.

  2013cites this paper
• COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs

  2013cites this paper
• RXR agonists inhibit high glucose-induced upregulation of inflammation by suppressing activation of the NADPH oxidase-nuclear factor-κB pathway in human endothelial cells.

  2013cites this paper
• 1 Vitamin A: Nutritional Aspects of Retinoids and Carotenoids

  2013cites this paper
• Disila-analogues of the synthetic retinoids EC23 and TTNN: synthesis, structure and biological evaluation.

  2012cites this paper
• 2 Molecularbiology of Basal Cell Carcinoma

  2012cites this paper
• Antagonist Effect of Triptolide on AKT Activation by Truncated Retinoid X Receptor-alpha

  2012cites this paper
• Molecularbiology of Basal Cell Carcinoma

  2012cites this paper
• 11. Vitamin A

  2012cites this paper
• Retinoid receptors and therapeutic applications of RAR/RXR modulators.

  2012cites this paper
• The retinoid X receptors and their ligands.

  2012cites this paper
• Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis

  2012cites this paper
• Retinoic acid receptor‐mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: Role of the renin‐angiotensin system

  2011cites this paper
• Retinoids regulate stem cell differentiation

  2011cites this paper
• Retinoic Acid Receptors

  2010cites this paper
• NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.

  2010cites this paper
• Modulating retinoid X receptor with a series of (E)-3-[4-hydroxy-3-(3-alkoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]acrylic acids and their 4-alkoxy isomers.

  2009cites this paper
• Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.

  2008cites this paper
• Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids.

  2008cites this paper
• New retinoid chemotypes: 9-cis-retinoic acid analogs with hydrophobic rings derived from terpenes as selective RAR agonists.

  2008cites this paper
• Retinoic Acid Analogues Inhibit Human Herpesvirus 8 Replication

  2008cites this paper
• Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter.

  2008cites this paper
• The Problem with Nutritionally Enhanced Plants

  2008cites this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cites this paper
• An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.

  2007cites this paper
• Retinoid signaling during spermatogenesis as revealed by genetic and metabolic manipulations of retinoic acid receptor alpha.

  2007cites this paper
• Advances in the Discovery of Acne and Rosacea Treatments

  2007cites this paper
• FOCUS :H YDROGEN EXCHANGE AND COVALENT MODIFICATION Investigation of Ligand Interactions with Human RXR by Hydrogen/Deuterium Exchange and Mass Spectrometry

  2006cites this paper
• NUCLEAR RECEPTORS

  2006cites this paper
• Retinoids have differing efficacies on alveolar regeneration in a dexamethasone-treated mouse.

  2006cites this paper
• All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer.

  2006cites this paper
• Investigation of ligand interactions with human RXRα by hydrogen/deuterium exchange and mass spectrometry

  2006cites this paper
• The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis.

  2005cites this paper
• Retinoids as therapeutic agents: today and tomorrow.

  2005cites this paper
• Ligand recognition by RAR and RXR receptors: binding and selectivity.

  2005cites this paper
• Nuclear Receptors

  2005cites this paper
• Determinants of retinoid X receptor transcriptional antagonism.

  2004cites this paper
• Guide to Receptors and Channels, 1st Edition

  2004cites this paper
• Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.

  2004cites this paper
• Structure-based design of potent retinoid X receptor alpha agonists.

  2004cites this paper
• Retinoid-induced limb malformations.

  2004cites this paper
• Actual targets in cytodifferentiation cancer therapy.

  2004cites this paper
• Selective retinoids and rexinoids in cancer therapy and chemoprevention.

  2002cites this paper